Biotech company with a royalty stream from a deal with GSK.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about AnaptysBio, Inc. in the last 30 days yet.
The 1 sources with the most insights about AnaptysBio, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Considered 'very, very exciting' and added to the speaker's long list due to its royalty stream, despite a noted history of wasting money.
Considered 'very, very exciting' and added to the speaker's long list due to its royalty stream, despite a noted history of wasting money.
Other assets that creators frequently mention in the same content as AnaptysBio, Inc..
The most active sources covering AnaptysBio, Inc. (ANAB) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about AnaptysBio, Inc. (ANAB) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering AnaptysBio, Inc. (ANAB) most frequently also discuss RGTI, QUBT, IONQ, JNJ, AVXL. See the "Discussed alongside" section above for full asset pages.